Quest Diagnostics (DGX) Stock Insights
DGX$245.62+3.06 +1.26%
$27.11B
Market Cap
23.83
P/E
21.72
Forward P/E
41
Score
Quest Diagnostics (DGX) Stock Insights
DGX price $245.62 +3.06 +1.26%
- Ticker
- DGX
- Price
- $245.62
- Change
- +3.06 +1.26%
- Market cap ?
- $27.11B
- P/E ?
- 23.83
- Forward P/E ?
- 21.72
- Dividend yield ?
- 1.39%
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Stocklytics score
- 41
- Value
- 37
- Quality
- 50
- Growth
- 37
Stocklytics score rationale: value 37, quality 50, growth 37.
Financials
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 7515000000 | 7709000000 | 7531000000 | 7726000000 | 9437000000 | 10788000000 | 9883000000 | 9252000000 | 9872000000 | 11035000000 |
Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus, New Jersey, is a premier provider of diagnostic testing, information, and related services, serving clients both domestically and internationally. Its core business involves the development and provision of diverse diagnostic information services, such as routine, advanced clinical, and anatomic pathology testing. While primarily…
Fair value
DGX fair value $218.10. Price $245.62. Price is 13% above fair value.
Above fair value, and more expensive than usual. A larger premium than on 96% of days in the past 5 years.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Calculated with a 10-year free-cash-flow discount. Starting free cash flow 1.38B. Growth 1.22%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 8.70% (beta 0.8). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 110.37M. Net debt 6.50B. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the median P/E of the company's industry. That median uses listed stocks worth at least $10 billion with a positive P/E of 100 or below, and the industry needs at least eight of them. Otherwise the sector median is used when that group also has at least eight, then the market median of those large companies. The multiple used is the lower of that median and 1.25 times the stock's own 10-year median P/E, then kept between 8 and 30. If the stock has no 10-year median, the peer median is kept between 8 and 30. Fair value is the average of the cash-flow value and the earnings value when both exist. Card and credit companies use the earnings value only, because changes in customer receivables distort free cash flow. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.
Earnings
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2027-02-09 | — | 2.68 | — | 3.04B |
| 2026-10-22 | 3.00 | 2.87 | 3.10B | 3.05B |
| 2026-07-23 | 3.12 | 2.82 | 3.04B | 2.97B |
| 2026-04-21 | 2.50 | 2.37 | 2.90B | 2.83B |
| 2026-02-10 | 2.42 | 2.36 | 2.81B | 2.75B |
| 2025-10-21 | 2.60 | 2.50 | 2.82B | 2.74B |
| 2025-07-22 | 2.62 | 2.57 | 2.76B | 2.73B |
| 2025-04-22 | 2.21 | 2.15 | 2.65B | 2.63B |
| 2025-01-30 | 2.23 | 2.19 | 2.62B | 2.58B |
| 2024-10-22 | 2.30 | 2.26 | 2.49B | 2.43B |
| 2024-07-23 | 2.35 | 2.34 | 2.40B | 2.39B |
| 2024-04-23 | 2.04 | 1.86 | 2.37B | 2.29B |
| 2024-02-01 | 2.15 | 2.11 | 2.29B | 2.25B |
| 2023-10-24 | 2.22 | 2.19 | 2.29B | 2.27B |
| 2023-07-26 | 2.30 | 2.27 | 2.34B | 2.25B |
| 2023-04-27 | 2.04 | 1.97 | 2.33B | 2.20B |
| 2023-02-02 | 1.98 | 1.90 | 2.33B | 2.26B |
| 2022-10-20 | 2.36 | 2.19 | 2.49B | 2.35B |
| 2022-07-21 | 2.36 | 2.29 | 2.45B | 2.34B |
| 2022-04-21 | 3.22 | 2.97 | 2.61B | 2.64B |
| 2022-02-03 | 3.33 | 3.18 | 2.74B | 2.68B |
| 2021-10-21 | 3.96 | 2.88 | 2.77B | 2.34B |
| 2021-07-22 | 3.18 | 2.87 | 2.55B | 2.25B |
| 2021-04-22 | 3.76 | 3.71 | 2.72B | 2.66B |
| 2021-02-04 | 4.48 | 4.24 | 3.00B | 2.83B |
| 2020-10-22 | 4.31 | 3.73 | 2.79B | 2.41B |
| 2020-07-23 | 1.42 | 1.41 | 1.83B | 1.81B |
| 2020-04-22 | 0.94 | 0.89 | 1.82B | 1.73B |
| 2020-01-30 | 1.67 | 1.60 | 1.93B | 1.85B |
| 2019-10-22 | 1.76 | 1.71 | 1.96B | 1.90B |
| 2019-07-23 | 1.73 | 1.68 | 1.95B | 1.90B |
| 2019-04-23 | 1.40 | 1.36 | 1.89B | 1.84B |
| 2019-02-14 | 1.36 | 1.36 | 1.84B | 1.85B |
| 2018-10-23 | 1.68 | 1.68 | 1.89B | 1.89B |
| 2018-07-24 | 1.75 | 1.76 | 1.92B | 1.93B |
| 2018-04-19 | 1.52 | 1.49 | 1.88B | 1.85B |
| 2018-02-01 | 1.40 | 1.38 | 1.94B | 1.84B |
| 2017-10-19 | 1.39 | 1.35 | 1.93B | 1.80B |
| 2017-07-25 | 1.55 | 1.42 | 1.94B | 1.71B |
| 2017-04-20 | 1.33 | 1.18 | 1.90B | 1.61B |
Dividends
Yield 1.38%. Payout ratio 32.68%. Frequency Quarterly.
Safety score 91/100 · Safe. Payout ratio is 33% of earnings. Dividends use less than 40% of free cash flow. Dividends were paid in 23 separate years. Yield is 1.4%, which is modest.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| 2026-10-06 | $0.86 | 2026-10-06 | 2026-10-21 | Quarterly |
| 2026-07-08 | $0.86 | 2026-07-08 | 2026-07-22 | Quarterly |
| 2026-04-06 | $0.86 | 2026-04-06 | 2026-04-20 | Quarterly |
| 2026-01-13 | $0.80 | 2026-01-13 | 2026-01-28 | Quarterly |
| 2025-10-03 | $0.80 | 2025-10-03 | 2025-10-20 | Quarterly |
| 2025-07-07 | $0.80 | 2025-07-07 | 2025-07-21 | Quarterly |
| 2025-04-07 | $0.80 | 2025-04-07 | 2025-04-21 | Quarterly |
| 2025-01-14 | $0.75 | 2025-01-14 | 2025-01-29 | Quarterly |
| 2024-10-04 | $0.75 | 2024-10-04 | 2024-10-21 | Quarterly |
| 2024-07-08 | $0.75 | 2024-07-08 | 2024-07-22 | Quarterly |
| 2024-04-05 | $0.75 | 2024-04-08 | 2024-04-22 | Quarterly |
| 2024-01-16 | $0.71 | 2024-01-17 | 2024-01-31 | Quarterly |
| 2023-10-05 | $0.71 | 2023-10-06 | 2023-10-23 | Quarterly |
| 2023-07-10 | $0.71 | 2023-07-11 | 2023-07-25 | Quarterly |
| 2023-04-06 | $0.71 | 2023-04-10 | 2023-04-24 | Quarterly |
| 2023-01-17 | $0.66 | 2023-01-18 | 2023-02-01 | Quarterly |
| 2022-10-03 | $0.66 | 2022-10-04 | 2022-10-19 | Quarterly |
| 2022-07-05 | $0.66 | 2022-07-06 | 2022-07-20 | Quarterly |
| 2022-06-03 | $0.66 | — | — | Irregular |
| 2022-04-05 | $0.66 | 2022-04-06 | 2022-04-20 | Quarterly |
| 2022-01-18 | $0.62 | 2022-01-19 | 2022-02-02 | Quarterly |
| 2021-10-04 | $0.62 | 2021-10-05 | 2021-10-20 | Quarterly |
| 2021-07-06 | $0.62 | 2021-07-07 | 2021-07-21 | Quarterly |
| 2021-04-06 | $0.62 | 2021-04-07 | 2021-04-21 | Quarterly |
| 2021-01-19 | $0.56 | 2021-01-20 | 2021-02-03 | Quarterly |
| 2020-10-05 | $0.56 | 2020-10-06 | 2020-10-21 | Quarterly |
| 2020-07-07 | $0.56 | 2020-07-08 | 2020-07-22 | Quarterly |
| 2020-04-06 | $0.56 | 2020-04-07 | 2020-04-21 | Quarterly |
| 2020-01-13 | $0.53 | 2020-01-14 | 2020-01-29 | Quarterly |
| 2019-10-03 | $0.53 | 2019-10-04 | 2019-10-21 | Quarterly |
| 2019-07-05 | $0.53 | 2019-07-08 | 2019-07-22 | Quarterly |
| 2019-04-05 | $0.53 | 2019-04-08 | 2019-04-22 | Quarterly |
| 2019-01-14 | $0.53 | 2019-01-15 | 2019-01-30 | Quarterly |
| 2018-10-04 | $0.50 | 2018-10-05 | 2018-10-22 | Quarterly |
| 2018-07-06 | $0.50 | 2018-07-09 | 2018-07-23 | Quarterly |
| 2018-04-03 | $0.50 | 2018-04-04 | 2018-04-18 | Quarterly |
| 2018-01-08 | $0.45 | 2018-01-09 | 2018-01-24 | Quarterly |
| 2017-10-02 | $0.45 | 2017-10-03 | 2017-10-18 | Quarterly |
| 2017-07-06 | $0.45 | 2017-07-10 | 2017-07-24 | Quarterly |
| 2017-04-03 | $0.45 | 2017-04-05 | 2017-04-19 | Quarterly |
| 2017-01-06 | $0.45 | 2017-01-10 | 2017-01-25 | Quarterly |
| 2016-09-30 | $0.40 | 2016-10-04 | 2016-10-19 | Quarterly |
| 2016-07-01 | $0.40 | 2016-07-06 | 2016-07-20 | Quarterly |
| 2016-04-04 | $0.40 | 2016-04-06 | 2016-04-20 | Quarterly |
| 2016-01-08 | $0.38 | 2016-01-12 | 2016-01-27 | Quarterly |
| 2015-10-02 | $0.38 | 2015-10-06 | 2015-10-21 | Quarterly |
| 2015-07-06 | $0.38 | 2015-07-08 | 2015-07-22 | Quarterly |
| 2015-04-06 | $0.38 | 2015-04-08 | 2015-04-22 | Quarterly |
| 2015-01-09 | $0.33 | 2015-01-13 | 2015-01-28 | Quarterly |
| 2014-10-03 | $0.33 | 2014-10-07 | 2014-10-22 | Quarterly |
| 2014-07-07 | $0.33 | 2014-07-09 | 2014-07-23 | Quarterly |
| 2014-04-04 | $0.33 | 2014-04-08 | 2014-04-23 | Quarterly |
| 2014-01-03 | $0.30 | 2014-01-07 | 2014-01-22 | Quarterly |
| 2013-09-27 | $0.30 | 2013-10-01 | 2013-10-16 | Quarterly |
| 2013-06-28 | $0.30 | 2013-07-02 | 2013-07-17 | Quarterly |
| 2013-03-28 | $0.30 | 2013-04-02 | 2013-04-16 | Quarterly |
| 2013-01-09 | $0.30 | 2013-01-11 | 2013-01-28 | Quarterly |
| 2012-09-27 | $0.17 | 2012-10-01 | 2012-10-16 | Quarterly |
| 2012-06-29 | $0.17 | 2012-07-03 | 2012-07-18 | Quarterly |
| 2012-03-30 | $0.17 | 2012-04-03 | 2012-04-17 | Quarterly |
| 2012-01-05 | $0.17 | 2012-01-09 | 2012-01-24 | Quarterly |
| 2011-10-05 | $0.10 | 2011-10-07 | 2011-10-24 | Quarterly |
| 2011-06-30 | $0.10 | 2011-07-05 | 2011-07-19 | Quarterly |
| 2011-04-01 | $0.10 | 2011-04-05 | 2011-04-19 | Quarterly |
| 2011-01-06 | $0.10 | 2011-01-10 | 2011-01-25 | Quarterly |
| 2010-09-30 | $0.10 | 2010-10-04 | 2010-10-19 | Quarterly |
| 2010-07-01 | $0.10 | 2010-07-06 | 2010-07-20 | Quarterly |
| 2010-04-01 | $0.10 | 2010-04-06 | 2010-04-20 | Quarterly |
| 2010-01-05 | $0.10 | 2010-01-07 | 2010-01-22 | Quarterly |
| 2009-09-30 | $0.10 | 2009-10-02 | 2009-10-19 | Quarterly |
| 2009-07-01 | $0.10 | 2009-07-06 | 2009-07-20 | Quarterly |
| 2009-04-02 | $0.10 | 2009-04-06 | 2009-04-20 | Quarterly |
| 2009-01-07 | $0.10 | 2009-01-09 | 2009-01-26 | Quarterly |
| 2008-10-01 | $0.10 | 2008-10-03 | 2008-10-20 | Quarterly |
| 2008-07-01 | $0.10 | 2008-07-03 | 2008-07-18 | Quarterly |
| 2008-04-02 | $0.10 | 2008-04-04 | 2008-04-18 | Quarterly |
| 2008-01-07 | $0.10 | 2008-01-09 | 2008-01-23 | Quarterly |
| 2007-10-01 | $0.10 | 2007-10-03 | 2007-10-17 | Quarterly |
| 2007-07-02 | $0.10 | 2007-07-05 | 2007-07-18 | Quarterly |
| 2007-04-02 | $0.10 | 2007-04-04 | 2007-04-18 | Quarterly |
Insider trades
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-10-26 | PFEIFFER GARY M | Sell | 1.20K | $243.00 | 292.33K |
| 2026-10-21 | CARTER ROBERT B | Buy | 10 | $235.93 | 2.36K |
| 2026-10-21 | SAMAD SAM | Buy | 90 | $235.94 | 21.23K |
| 2026-10-21 | Gregg Vicky B | Buy | 63 | $235.94 | 14.86K |
| 2026-10-21 | KUPPUSAMY KARTHIK | Buy | 33 | $235.94 | 7.79K |
| 2026-10-21 | Lassiter Wright III | Buy | 6 | $235.96 | 1.42K |
| 2026-10-21 | Plewman Patrick | Buy | 41 | $235.94 | 9.67K |
| 2026-10-21 | MAIN TIMOTHY L | Buy | 18 | $235.94 | 4.25K |
| 2026-10-21 | DELANEY MARK E | Buy | 25 | $235.94 | 5.90K |
| 2026-10-01 | WENTWORTH TIMOTHY C | Buy | 135 | — | — |
| 2026-09-01 | Davis J. E. | Sell | 10.00K | $242.72 | 2.43M |
| 2026-08-28 | PREVOZNIK MICHAEL E | Buy | 22.68K | $112.17 | 2.54M |
| 2026-08-28 | PREVOZNIK MICHAEL E | Sell | 16.01K | $242.88 | 3.89M |
| 2026-08-28 | PREVOZNIK MICHAEL E | Sell | 6.24K | $243.63 | 1.52M |
| 2026-08-28 | PREVOZNIK MICHAEL E | Sell | 430 | $244.51 | 105.14K |
| 2026-08-28 | PREVOZNIK MICHAEL E | Sell | 1.00K | — | — |
| 2026-08-28 | PREVOZNIK MICHAEL E | Sell | 22.68K | $112.17 | 2.54M |
| 2026-07-28 | DELANEY MARK E | Sell | 1.60K | $235.18 | 376.29K |
| 2026-07-22 | KUPPUSAMY KARTHIK | Buy | 37 | $206.81 | 7.65K |
| 2026-07-22 | CARTER ROBERT B | Buy | 11 | $206.80 | 2.27K |
| 2026-07-22 | Gregg Vicky B | Buy | 72 | $206.81 | 14.89K |
| 2026-07-22 | Plewman Patrick | Buy | 46 | $206.81 | 9.51K |
| 2026-07-22 | MAIN TIMOTHY L | Buy | 21 | $206.81 | 4.34K |
| 2026-07-22 | SAMAD SAM | Buy | 102 | $206.81 | 21.09K |
| 2026-07-22 | Lassiter Wright III | Buy | 6 | $206.81 | 1.24K |
| 2026-07-22 | DELANEY MARK E | Buy | 34 | $206.81 | 7.03K |
| 2026-07-01 | WENTWORTH TIMOTHY C | Buy | 144 | — | — |
| 2026-06-04 | KUPPUSAMY KARTHIK | Buy | 4.83K | $121.81 | 587.95K |
| 2026-06-04 | KUPPUSAMY KARTHIK | Buy | 3.32K | $127.72 | 424.05K |
| 2026-06-04 | KUPPUSAMY KARTHIK | Sell | 8.15K | $200.00 | 1.63M |
| 2026-06-04 | KUPPUSAMY KARTHIK | Sell | 3.32K | $127.72 | 424.05K |
| 2026-06-04 | KUPPUSAMY KARTHIK | Sell | 4.83K | $121.81 | 587.95K |
| 2026-06-01 | Davis J. E. | Sell | 10.00K | $194.14 | 1.94M |
| 2026-05-20 | CARTER ROBERT B | Buy | 1.14K | — | — |
| 2026-05-20 | Gregg Vicky B | Buy | 1.14K | — | — |
| 2026-05-20 | Diaz Luis | Buy | 1.14K | — | — |
| 2026-05-20 | MAIN TIMOTHY L | Buy | 1.14K | — | — |
| 2026-05-20 | WENTWORTH TIMOTHY C | Buy | 1.14K | — | — |
| 2026-05-20 | Doi Tracey | Buy | 1.14K | — | — |
| 2026-05-20 | RING TIMOTHY M | Buy | 1.14K | — | — |
| 2026-05-20 | Lassiter Wright III | Buy | 1.14K | — | — |
| 2026-05-20 | MORRISON DENISE M | Buy | 1.14K | — | — |
| 2026-05-20 | PFEIFFER GARY M | Buy | 1.14K | — | — |
| 2026-04-20 | SAMAD SAM | Buy | 108 | $194.70 | 21.03K |
| 2026-04-20 | Plewman Patrick | Buy | 49 | $194.70 | 9.54K |
| 2026-04-20 | Gregg Vicky B | Buy | 68 | $194.70 | 13.24K |
| 2026-04-20 | CARTER ROBERT B | Buy | 7 | $194.70 | 1.36K |
| 2026-04-20 | Lassiter Wright III | Buy | 6 | $194.70 | 1.17K |
| 2026-04-20 | KUPPUSAMY KARTHIK | Buy | 39 | $194.70 | 7.59K |
| 2026-04-20 | DELANEY MARK E | Buy | 37 | $194.70 | 7.20K |
| 2026-04-01 | WENTWORTH TIMOTHY C | Buy | 198 | — | — |
| 2026-03-09 | WENTWORTH TIMOTHY C | Buy | 215 | — | — |
| 2026-03-09 | WENTWORTH TIMOTHY C | Other | 0 | — | — |
| 2026-03-05 | Doherty Catherine T. | Sell | 5.56K | $206.21 | 1.15M |
| 2026-03-05 | PREVOZNIK MICHAEL E | Sell | 3.88K | $206.21 | 799.68K |
| 2026-03-05 | Plewman Patrick | Sell | 2.85K | $206.21 | 588.73K |
| 2026-03-04 | SAMAD SAM | Buy | 13.95K | $204.86 | 2.86M |
| 2026-03-04 | SAMAD SAM | Sell | 7.72K | $204.86 | 1.58M |
| 2026-03-04 | Doherty Catherine T. | Buy | 11.36K | $204.86 | 2.33M |
| 2026-03-04 | Doherty Catherine T. | Sell | 5.81K | $204.86 | 1.19M |
| 2026-03-04 | DELANEY MARK E | Buy | 5.68K | $204.86 | 1.16M |
| 2026-03-04 | DELANEY MARK E | Sell | 2.33K | $204.86 | 476.50K |
| 2026-03-04 | PREVOZNIK MICHAEL E | Buy | 7.23K | $204.86 | 1.48M |
| 2026-03-04 | PREVOZNIK MICHAEL E | Sell | 3.35K | $204.86 | 687.10K |
| 2026-03-04 | Davis J. E. | Buy | 51.65K | $204.86 | 10.58M |
| 2026-03-04 | Davis J. E. | Sell | 26.41K | $204.86 | 5.41M |
| 2026-03-04 | Plewman Patrick | Buy | 5.68K | $204.86 | 1.16M |
| 2026-03-04 | Plewman Patrick | Sell | 2.83K | $204.86 | 579.14K |
| 2026-03-04 | Deppe Michael J | Buy | 1.47K | $204.86 | 301.76K |
| 2026-03-04 | Deppe Michael J | Sell | 750 | $204.86 | 153.65K |
| 2026-03-04 | KUPPUSAMY KARTHIK | Buy | 6.20K | $204.86 | 1.27M |
| 2026-03-04 | KUPPUSAMY KARTHIK | Sell | 2.63K | $204.86 | 538.37K |
| 2026-03-03 | Doherty Catherine T. | Sell | 632 | $207.73 | 131.29K |
| 2026-03-03 | PREVOZNIK MICHAEL E | Sell | 526 | $207.73 | 109.27K |
| 2026-03-03 | Plewman Patrick | Sell | 410 | $207.73 | 85.17K |
| 2026-03-02 | Doherty Catherine T. | Sell | 648 | $204.86 | 132.75K |
| 2026-03-02 | SAMAD SAM | Sell | 869 | $204.86 | 178.02K |
| 2026-03-02 | PREVOZNIK MICHAEL E | Sell | 288 | $204.86 | 59.00K |
| 2026-03-02 | Davis J. E. | Sell | 2.97K | $204.86 | 608.02K |
| 2026-03-02 | Davis J. E. | Sell | 10.00K | $212.52 | 2.13M |
| 2026-03-02 | Plewman Patrick | Sell | 230 | $204.86 | 47.12K |
| 2026-03-02 | KUPPUSAMY KARTHIK | Sell | 205 | $204.86 | 42.00K |
| 2026-03-02 | DELANEY MARK E | Sell | 188 | $204.86 | 38.51K |
| 2026-03-02 | Deppe Michael J | Sell | 88 | $204.86 | 18.03K |
| 2026-02-19 | Plewman Patrick | Sell | 958 | $204.83 | 196.23K |
| 2026-02-19 | PREVOZNIK MICHAEL E | Sell | 1.11K | $204.83 | 227.57K |
| 2026-02-19 | Doherty Catherine T. | Sell | 1.43K | $204.83 | 293.52K |
| 2026-02-18 | Plewman Patrick | Buy | 1.95K | — | — |
| 2026-02-18 | Plewman Patrick | Sell | 244 | $210.01 | 51.24K |
| 2026-02-18 | Plewman Patrick | Sell | 293 | $206.99 | 60.65K |
| 2026-02-18 | Plewman Patrick | Buy | 9.01K | $204.96 | 1.85M |
| 2026-02-18 | SAMAD SAM | Buy | 3.96K | — | — |
| 2026-02-18 | SAMAD SAM | Sell | 855 | $210.01 | 179.56K |
| 2026-02-18 | SAMAD SAM | Sell | 1.01K | $206.99 | 209.06K |
| 2026-02-18 | SAMAD SAM | Buy | 18.30K | $204.96 | 3.75M |
| 2026-02-18 | PREVOZNIK MICHAEL E | Buy | 2.01K | — | — |
| 2026-02-18 | PREVOZNIK MICHAEL E | Sell | 301 | $210.01 | 63.21K |
| 2026-02-18 | PREVOZNIK MICHAEL E | Sell | 347 | $206.99 | 71.83K |
| 2026-02-18 | PREVOZNIK MICHAEL E | Buy | 9.29K | $204.96 | 1.90M |
| 2026-02-18 | Davis J. E. | Buy | 15.86K | — | — |
Institutional holders
Latest filed quarter: Q2 2026.
Institutions holding: 1.13K, holders +43 vs prior quarter. Ownership 96.07%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| BLACKROCK, INC. | 9.28M | 103.12K | +1.12% | 1.97B |
| VANGUARD CAPITAL MANAGEMENT LLC | 7.23M | 87.72K | +1.23% | 1.53B |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 6.13M | 49.65K | +0.82% | 1.30B |
| STATE STREET CORP | 5.52M | 135.82K | +2.52% | 1.17B |
| PRICE T ROWE ASSOCIATES INC /MD/ | 5.44M | -853.00K | -13.54% | 1.15B |
| BOSTON PARTNERS | 4.74M | 732.24K | +18.25% | 1.00B |
| JPMORGAN CHASE & CO | 3.52M | -326.02K | -8.48% | 748.59M |
| GEODE CAPITAL MANAGEMENT, LLC | 3.14M | 51.56K | +1.67% | 662.58M |
| MORGAN STANLEY | 2.46M | -19.22K | -0.78% | 521.50M |
| EDGEPOINT INVESTMENT GROUP INC. | 2.25M | 3.70K | +0.16% | 476.37M |
| DIMENSIONAL FUND ADVISORS LP | 1.99M | 38.51K | +1.98% | 421.38M |
| BANK OF AMERICA CORP /DE/ | 1.94M | 182.23K | +10.40% | 410.15M |
| GRANTHAM, MAYO, VAN OTTERLOO & CO. LLC | 1.89M | 5.18K | +0.28% | 400.21M |
| WELLS FARGO & COMPANY/MN | 1.75M | -11.55K | -0.66% | 371.17M |
| DAVIS SELECTED ADVISERS | 1.56M | -62.20K | -3.84% | 329.78M |
| VICTORY CAPITAL MANAGEMENT INC | 1.55M | -295.78K | -16.02% | 328.64M |
| NORGES BANK | 1.41M | 1.41M | New | 298.13M |
| FMR LLC | 1.40M | 456.52K | +48.45% | 296.46M |
| INVESCO LTD. | 1.38M | -259.37K | -15.83% | 292.30M |
| NORTHERN TRUST CORP | 1.13M | 13.23K | +1.19% | 238.96M |
| GOLDMAN SACHS GROUP INC | 982.69K | -366.00K | -27.14% | 208.28M |
| UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC | 942.41K | 95.80K | +11.32% | 199.74M |
| UBS GROUP AG | 888.91K | 186.57K | +26.56% | 188.40M |
| AMERICAN CENTURY COMPANIES INC | 818.22K | -49.11K | -5.66% | 173.42M |
| M&G PLC | 795.65K | -9.69K | -1.20% | 168.68M |
Insights
- Revenue by product
| Period | Value |
|---|---|
| FY2011 | Clinical Laboratory Testing Business: 6814456000.0, Other Segments: 696034000.0 |
| FY2012 | Clinical Laboratory Testing Business: 6819916000.0, Other Segments: 562646000.0 |
| FY2013 | Clinical Laboratory Testing Business: 6587000000.0, Other Segments: 559000000.0 |
| FY2014 | Clinical Laboratory Testing Business: 6873000000.0, Other Segments: 562000000.0 |
| FY2015 | Diagnostic Information Services Business: 6965000000.0, Other Segments: 528000000.0 |
| FY2016 | Anatomic pathology testing services: 624000000.0, Other Segments: 377000000.0, Routine clinical testing services: 4179000000.0 |
| FY2017 | Anatomic pathology testing services: 612000000.0, Other Segments: 339000000.0, Routine clinical testing services: 4309000000.0 |
| FY2018 | Anatomic pathology testing services: 578000000.0, Other Segments: 327000000.0, Routine clinical testing services: 4217000000.0 |
| FY2019 | Anatomic pathology testing services: 579000000.0, Other Segments: 321000000.0, Routine clinical testing services: 4206000000.0 |
| FY2020 | All other services: 298000000.0, Anatomic pathology testing services: 482000000.0, COVID-19 Testing Services: 2723000000.0, Gene-based and esoteric testing services: 2098000000.0, Routine clinical testing services: 3836000000.0 |
| FY2021 | All other services: 294000000.0, Anatomic pathology testing services: 553000000.0, COVID-19 Testing Services: 2770000000.0, Gene-based and esoteric testing services: 2878000000.0, Routine clinical testing services: 4293000000.0 |
| FY2022 | Diagnostic Information Services Business: 9609000000.0, Other Segments: 274000000.0 |
| FY2023 | Diagnostic Information Services Business: 8976000000.0, Other Segments: 276000000.0 |
| FY2024 | Diagnostic Information Services Business: 9614000000.0 |
| FY2025 | Diagnostic Information Services Business: 10785000000.0 |
Insights · Dividends · Forecast · Financials · Learn